Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3,203,885
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
2,601,860
-
Shares change
-
+1,839
-
Total reported value, excl. options
-
$241,516,691
-
Value change
-
+$243,574
-
Number of buys
-
29
-
Number of sells
-
-26
-
Price
-
$92.83
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q3 2021
74 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q3 2021.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,601,860 shares
of 3,203,885 outstanding shares and own 81.21% of the company stock.
Largest 10 shareholders include FMR LLC (496,863 shares), PRICE T ROWE ASSOCIATES INC /MD/ (281,385 shares), RENAISSANCE TECHNOLOGIES LLC (230,035 shares), BlackRock Inc. (216,259 shares), VANGUARD GROUP INC (215,693 shares), DIMENSIONAL FUND ADVISORS LP (151,501 shares), RICE HALL JAMES & ASSOCIATES, LLC (114,785 shares), JPMORGAN CHASE & CO (93,656 shares), Russell Investments Group, Ltd. (76,803 shares), and Ranger Investment Management, L.P. (68,719 shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.